NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ZYXI

Zynex Inc

Jul 14 • 02:42PM ET

2.05

Dollar change -0.19
Percentage change -8.48	%

Healthcare • Medical Distribution • USA • NASD

Peers: MDT SYK BSX ZBH IART GMED PODD TNDM CNMD AORT

| Held by: VTI VXF VTWO IWC EES AVSC SQLV VTWG IWM PKW

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.24	Insider Own	41.24%	Shs Outstand	30.23M	Perf Week	-18.33%
Market Cap	61.99M	Forward P/E	-	EPS next Y	-0.37	Insider Trans	-0.16%	Shs Float	17.77M	Perf Month	0.49%
Enterprise Value	111.18M	PEG	-	EPS next Q	-0.20	Inst Own	21.82%	Short Float	20.14%	Perf Quarter	-4.65%
Income	-7.41M	P/S	0.36	EPS this Y	-970.37%	Inst Trans	-20.57%	Short Ratio	15.76	Perf Half Y	-74.50%
Sales	172.40M	P/B	2.98	EPS next Y	52.77%	ROA	-6.39%	Short Interest	3.58M	Perf YTD	-74.41%
Book/sh	0.69	P/C	2.60	EPS next 5Y	-	ROE	-27.52%	52W High	10.62 -80.70%	Perf Year	-77.17%
Cash/sh	0.79	P/FCF	-	EPS past 3/5Y	-38.41% -18.26%	ROIC	-8.29%	52W Low	1.66 23.49%	Perf 3Y	-75.68%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	13.86% 33.44%	Gross Margin	77.67%	Volatility	6.64% 7.90%	Perf 5Y	-91.25%
Dividend TTM	-	EV/Sales	0.64	EPS Y/Y TTM	-202.31%	Oper. Margin	-4.43%	ATR (14)	0.18	Perf 10Y	1849.59%
Dividend Ex-Date	Jan 05, 2022	Quick Ratio	2.63	Sales Y/Y TTM	-8.63%	Profit Margin	-4.30%	RSI (14)	37.45	Recom	2.33
Dividend Gr. 3/5Y	- -	Current Ratio	3.46	EPS Q/Q	-109766.67%	SMA20	-15.43%	Beta	0.92	Target Price	6.00
Payout	0.00%	Debt/Eq	3.52	Sales Q/Q	-42.88%	SMA50	-10.86%	Rel Volume	0.95	Prev Close	2.24
Employees	1000	LT Debt/Eq	3.31	Earnings	Apr 29 AMC	SMA200	-63.44%	Avg Volume	227.08K	Price	2.05
IPO	Dec 05, 2002	Option/Short	Yes / Yes	EPS/Sales Surpr.	-37.50% -13.80%	Trades		Volume	174,270	Change	-8.48%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-12-25	Downgrade	RBC Capital Mkts	Outperform → Sector Perform	$11 → $5.50
Mar-12-25	Downgrade	Ladenburg Thalmann	Buy → Neutral
Oct-16-23	Initiated	RBC Capital Mkts	Outperform	$13
Jan-06-23	Upgrade	Piper Sandler	Neutral → Overweight	$10 → $18
Feb-28-22	Reiterated	B. Riley Securities	Buy	$15.50 → $10
Jul-16-21	Upgrade	B. Riley Securities	Neutral → Buy	$19.50
Jul-16-21	Upgrade	B. Riley Securities	Neutral → Buy	$19 → $19.50
Mar-09-21	Upgrade	Northland Capital	Market Perform → Outperform	$22.50
Feb-26-21	Downgrade	B. Riley Securities	Buy → Neutral	$19
Jan-29-21	Downgrade	Piper Sandler	Overweight → Neutral	$28 → $20
Jan-28-21	Downgrade	Northland Capital	Outperform → Market Perform	$22.50
Sep-14-20	Upgrade	H.C. Wainwright	Neutral → Buy	$25
Sep-09-20	Upgrade	Northland Capital	Market Perform → Outperform	$22.50
Jul-29-20	Upgrade	B. Riley FBR	Neutral → Buy	$28
Jul-20-20	Initiated	Piper Sandler	Overweight	$30
Jul-13-20	Downgrade	B. Riley FBR	Buy → Neutral
Jul-10-20	Reiterated	H.C. Wainwright	Neutral	$20 → $30
Jun-16-20	Downgrade	Northland Capital	Outperform → Market Perform
May-19-20	Downgrade	H.C. Wainwright	Buy → Neutral	$20
Apr-01-20	Initiated	Northland Capital	Outperform	$15

Show Previous Ratings

Jul-02-25 05:15PM	Tricare Temporary Payment Suspension Update (PR Newswire) -10.78%
Jun-30-25 09:15AM	Zynex Announces Steven Dyson as New CEO (PR Newswire)
Jun-25-25 09:15AM	Zynex Announces Award of UK Patent for Non-Invasive Detection of Sepsis (PR Newswire)
May-23-25 11:58AM	Here's Why Zynex (ZYXI) Fell in Q1 (Insider Monkey)
May-15-25 02:09PM	Investor Lawsuit Accuses Medical Device Maker Zynex (ZYXI) of Inflating Revenue Through Excessive Shipments; Subsequent Earnings Report Reveals Significant Financial Strain- Hagens Berman (Newsfile)
09:51AM	Loading…
May-13-25 09:51AM	Zynex announces submission of 510(k) application for laser pulse oximeter (Medical Device Network)
May-12-25 09:15AM	Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter (PR Newswire)
May-06-25 05:45AM	Investors in Zynex, Inc. Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
May-02-25 04:55AM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms - Hagens Berman (Newsfile) +14.93%
Apr-30-25 07:35AM	Q1 2025 Zynex Inc Earnings Call (Thomson Reuters StreetEvents) -25.56%
03:15AM	Zynex Inc (ZYXI) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic ... (GuruFocus.com)
Apr-29-25 06:57PM	Zynex, Inc. (ZYXI) Q1 2025 Earnings Call Transcript (Seeking Alpha)
05:40PM	Zynex Inc. (ZYXI) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:02PM	Zynex Reports First Quarter 2025 Financial Results (PR Newswire)
05:45AM	Shareholders of Zynex, Inc. Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
02:03PM	Loading…
Apr-25-25 02:03PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
Apr-24-25 10:19AM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms - Hagens Berman (Newsfile)
Apr-23-25 07:05PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire) +7.96%
Apr-22-25 09:15AM	Zynex Sets First Quarter 2025 Earnings Call (PR Newswire) +6.10%
08:55AM	Rewey Asset Management Q1 2025 Investment Letter (Seeking Alpha)
Apr-21-25 08:38AM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
Apr-18-25 02:57PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
05:45AM	Zynex, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
Apr-17-25 12:22PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms - Hagens Berman (Newsfile)
Apr-16-25 05:32PM	RBC Capital Further Trims Zynex (ZYXI) Target, Investor Lawsuit Looms Hagens Berman (GlobeNewswire)
Apr-14-25 08:42AM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire)
Apr-13-25 10:44AM	The 1-Minute Market Report April 13, 2025 (Seeking Alpha)
Apr-11-25 01:34PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire)
Apr-10-25 04:27AM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit - Hagens Berman (Newsfile) -8.51%
Apr-09-25 04:31PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire) +11.37%
04:32PM	Loading…
Apr-07-25 04:32PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire)
Apr-04-25 07:35AM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit - Hagens Berman (Newsfile)
Apr-03-25 01:43PM	Zynex, Inc. (ZYXI) Shares Under Pressure Amid Tricare Payment Halt, Dim Outlook, and Investor Lawsuit Hagens Berman (GlobeNewswire) -7.79%
Apr-01-25 12:25PM	Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Zynex, Inc. (ZYXI) (Newsfile) +12.73%
05:45AM	Zynex, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights - ZYXI (PR Newswire)
Mar-31-25 11:45AM	Wolf Haldenstein informs investors that Zynex, Inc. has been sued (GlobeNewswire)
08:05AM	The 1-Minute Market Report March 30, 2025 (Seeking Alpha)
Mar-27-25 01:04PM	Investors in Zynex, Inc. Should Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights ZYXI (GlobeNewswire)
12:25PM	Scott+Scott Attorneys at Law LLP Reminds Investors a Securities Action Has Been Filed Against Zynex, Inc. (ZYXI) (Newsfile)
09:02AM	Wolf Haldenstein informs investors that Zynex, Inc. has been sued (PR Newswire)
Mar-26-25 05:14PM	Wolf Haldenstein informs investors that Zynex, Inc. has been sued (GlobeNewswire)
Mar-22-25 11:00AM	Investors To Focus On PCE Price Index Print As Cintas, Lululemon To Report Earnings (SeekingAlpha)
Mar-12-25 07:46AM	Q4 2024 Zynex Inc Earnings Call (Thomson Reuters StreetEvents) -51.29%
03:06AM	Zynex Inc (ZYXI) Q4 2024 Earnings Call Highlights: Navigating Challenges and Opportunities (GuruFocus.com)
Mar-11-25 05:35PM	Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:08PM	Zynex Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire)
Mar-03-25 09:15AM	Zynex Sets Fourth Quarter and Year End 2024 Earnings Call (PR Newswire)
Dec-17-24 09:15AM	Zynex Announces Partnership To Conduct Business with Veterans Affairs (VA) Medical Centers, the Largest Healthcare Network in the United States (PR Newswire)
Dec-12-24 09:15AM	Zynex UCSF Study Results Demonstrate Laser Technology Benefits in Resolving Racial Bias of Current LED Pulse Oximeters (PR Newswire)
Dec-06-24 10:44AM	Zynex completes clinical verification trial of pulse oximeter (Medical Device Network)
Dec-05-24 09:15AM	Zynex Announces Completion of Its Laser Pulse Oximetry Trial (PR Newswire)
Dec-03-24 09:15AM	Zynex Announces Open Oximetry Project Membership (PR Newswire)
Nov-05-24 07:00AM	Building Momentum: Zynex Inc.'s (NASDAQ: ZYXI) Steady Rise in the Pain Management Market (News Direct)
Oct-25-24 12:26PM	Q3 2024 Zynex Inc Earnings Call (Thomson Reuters StreetEvents) +6.17%
03:20AM	Zynex Inc (ZYXI) Q3 2024 Earnings Call Highlights: Navigating Growth and Challenges (GuruFocus.com)
Oct-24-24 05:10PM	Zynex Inc. (ZYXI) Tops Q3 Earnings Estimates (Zacks)
04:01PM	Zynex Reports Third Quarter 2024 Financial Results (PR Newswire)
Oct-16-24 09:15AM	Zynex Sets Third Quarter 2024 Earnings Call (PR Newswire)
Oct-09-24 07:50AM	Zynex price target lowered to $11 from $12 at RBC Capital (TipRanks)
Sep-04-24 09:53AM	FDA clears Zynexs TensWave device for pain management (Medical Device Network)
09:15AM	Zynex to Present at the HC Wainwright Global Investment Conference (PR Newswire)
Sep-03-24 09:15AM	Zynex Obtains FDA clearance for new Pain Management Device (PR Newswire)
Aug-09-24 01:02AM	Insider Sale: COO Anna Lucsok Sells 24,875 Shares of Zynex Inc (ZYXI) (GuruFocus.com)
Jul-31-24 09:42AM	Zynex Inc. CEO Thomas Sandgaard Discusses Significant Company Growth and Future Innovations (News Direct) +9.49%
Jul-26-24 04:37PM	Why Zynex Plunged Today (Motley Fool) -12.37% -6.61%
12:34PM	Q2 2024 Zynex Inc Earnings Call (Thomson Reuters StreetEvents)
07:36AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jul-25-24 05:35PM	Zynex Inc. (ZYXI) Q2 Earnings and Revenues Lag Estimates (Zacks)
04:01PM	Zynex Reports Second Quarter 2024 Financial Results (PR Newswire)
Jul-17-24 09:15AM	Zynex Sets Second Quarter 2024 Earnings Call (PR Newswire)
Jul-11-24 09:15AM	Zynex Recognized as a Best Company to Work For by U.S. News & World Report and Top Workplaces (PR Newswire)
Jun-26-24 12:00PM	All You Need to Know About Zynex (ZYXI) Rating Upgrade to Buy (Zacks)
Jun-24-24 06:00AM	3 Short-Squeeze Stocks Poised for a Jaw-Dropping Rally (InvestorPlace)
Jun-19-24 06:00AM	Analyst Predictions: 3 Stocks Pegged to Soar Over 40% in One Year (InvestorPlace)
Jun-12-24 09:40AM	Is Zynex (ZYXI) Stock Undervalued Right Now? (Zacks)
Jun-10-24 09:30AM	Zynex to Participate in Fireside Chat with RBC Capital Markets on Thursday, June 13, 2024 (PR Newswire)
May-27-24 09:40AM	Should Value Investors Buy Zynex (ZYXI) Stock? (Zacks)
May-23-24 12:45PM	Zynex (ZYXI) is an Incredible Growth Stock: 3 Reasons Why (Zacks)
May-09-24 09:40AM	Are Investors Undervaluing Zynex (ZYXI) Right Now? (Zacks)
09:15AM	Zynex to Present at the RBC Capital Markets Global Healthcare Conference (PR Newswire)
May-07-24 12:45PM	3 Reasons Growth Investors Will Love Zynex (ZYXI) (Zacks)
09:15AM	Zynex Executives Recognized Among Top 25 in Medical Technology (PR Newswire)
May-02-24 08:55AM	Zynex, Inc. (NASDAQ:ZYXI) Q1 2024 Earnings Call Transcript (Insider Monkey)
07:01AM	Zynex Inc (ZYXI) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges and Seizing ... (GuruFocus.com)
Apr-30-24 08:58PM	ZYXI Stock Earnings: Zynex Misses Revenue for Q1 2024 (InvestorPlace) +7.29%
05:44PM	Zynex Inc (ZYXI) Q1 2024 Earnings: Revenue Meets Expectations, EPS Falls Short (GuruFocus.com)
04:01PM	Zynex Reports First Quarter 2024 Financial Results (PR Newswire)
Apr-18-24 09:15AM	Zynex Sets First Quarter 2024 Earnings Call (PR Newswire) -5.14%
Apr-02-24 02:58PM	3 Industrial Stocks Short Sellers Are Hammering: Cracks in the Foundation? (InvestorPlace)
09:15AM	Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award (PR Newswire)
Mar-02-24 08:43AM	Zynex, Inc. (NASDAQ:ZYXI) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-01-24 12:05PM	Zynex Price Target Raised by RBC Capital, HC Wainwright Analysts (Exec Edge) -9.29%
Feb-29-24 05:20PM	Zynex Inc. (ZYXI) Q4 Earnings and Revenues Miss Estimates (Zacks)
04:39PM	Zynex Inc (ZYXI) Reports 17% Revenue Growth in FY 2023, Announces New $20 Million Stock ... (GuruFocus.com)
04:01PM	Zynex Reports Fourth Quarter and Full Year 2023 Financial Results (PR Newswire)
Feb-22-24 09:15AM	Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call (PR Newswire)
Feb-20-24 09:15AM	Zynex Introduces New Products (PR Newswire)
Feb-08-24 09:00AM	Sichenzia Ross Ference Carmel LLP Closes Over 100 Capital Markets Transactions Valued At Over $700 Million in 2023 (GlobeNewswire)
Feb-06-24 09:15AM	Zynex Receives FDA Clearance for its Next Generation NMES Device (PR Newswire)
Feb-02-24 09:15AM	Zynex Recognized in Top 25 Medical Device Companies for 2024 (PR Newswire)

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Mar 03 '25	Sale	7.15	10,000	71,500	10,050	Mar 05 07:58 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Feb 03 '25	Sale	7.68	10,000	76,800	19,738	Feb 03 07:00 PM
Daniel Moorhead	Officer	Feb 03 '25	Proposed Sale	7.84	20,000	156,800		Feb 03 09:00 AM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Jan 02 '25	Sale	7.88	10,000	78,800	26,299	Jan 03 07:00 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Dec 02 '24	Sale	8.08	10,000	80,800	35,190	Dec 03 07:00 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 14 '24	Sale	8.09	2,000	16,180	14,603,662	Nov 18 07:00 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 12 '24	Sale	9.24	2,000	18,480	14,607,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 07 '24	Sale	9.17	2,000	18,340	14,613,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 11 '24	Sale	9.09	2,000	18,180	14,609,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 08 '24	Sale	8.77	2,000	17,540	14,611,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 13 '24	Sale	8.37	2,000	16,740	14,605,662	Nov 13 06:03 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 06 '24	Sale	8.82	2,000	17,640	14,615,662	Nov 06 08:05 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 04 '24	Sale	8.67	2,000	17,340	14,619,350	Nov 06 08:05 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 05 '24	Sale	8.05	2,000	16,100	14,617,662	Nov 06 08:05 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Nov 01 '24	Sale	8.59	10,000	85,900	44,878	Nov 04 06:00 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Oct 30 '24	Sale	8.92	2,000	17,840	14,625,350	Nov 01 06:39 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Oct 31 '24	Sale	8.82	2,000	17,640	14,623,350	Nov 01 06:39 PM
Sandgaard Thomas	PRESIDENT, CEO AND CHAIRMAN	Nov 01 '24	Sale	8.63	2,000	17,260	14,621,350	Nov 01 06:39 PM
Daniel Moorhead	Officer	Nov 01 '24	Proposed Sale	8.63	30,000	258,900		Nov 01 09:20 AM
Sandgaard Thomas	Officer	Oct 30 '24	Proposed Sale	8.92	100,000	892,000		Oct 30 12:01 PM
Lucsok Anna	CHIEF OPERATING OFFICER	Aug 06 '24	Sale	8.01	16,792	134,504	25,063	Aug 08 07:05 PM
Lucsok Anna	CHIEF OPERATING OFFICER	Aug 07 '24	Sale	8.03	8,083	64,906	16,980	Aug 08 07:05 PM
Disbrow Joshua R.	Director	Jul 29 '24	Buy	8.32	7,000	58,233	72,000	Jul 30 06:25 PM
MOORHEAD DANIEL J	CHIEF FINANCIAL OFFICER	Jul 30 '24	Sale	8.24	15,000	123,600	46,571	Jul 30 06:23 PM
Daniel Moorhead	Officer	Jul 30 '24	Proposed Sale	8.34	15,000	125,100		Jul 30 09:00 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ZYXI

Zynex Inc

Upgrade your FINVIZ experience